POLYSPECIFIC ANTIBODIES Russian patent published in 2015 - IPC C07K16/28 C07K16/22 C12N15/13 A61K39/395 A61P35/00 

Abstract RU 2547596 C2

FIELD: medicine.

SUBSTANCE: invention refers to biotechnology, more specifically to biospecific antibodies, and can be used in medicine. Constructed is an antibody containing one of the following groups of six hypervariable region (HVR) sequences: (a) HVR-L1 containing the sequence NIAKTISGY; (b) HVR-L2, containing the sequence WGSFLY; (c) HVR-L3 containing the sequence HYSSPP; (d) HVR-H1 containing the sequence NIKDTY; (e) HVR-H2 containing the sequence RIYPTNGYTR; and (f) HVR-H3 containing the sequence WGGDGFYAMD; or (a) HVR-L1 containing the sequence NIAKTISGY; (b) HVR-L2 containing the sequence WGSFLY; (c) HVR-L3 containing the sequence HYSSPP; (d) HVR-H1 containing the sequence NISGTY; (e) HVR-H2 containing the sequence RIYPSEGYTR; and (f) HVR-H3 containing the sequence WVGVGFYAMD. The produced antibody specifically binds human epidermal growth factor receptor 2 (HER2) and vascular endothelial growth factor (VEGF) The invention also refers to a recovered Fab fragment of the above antibody, a polynucleotide coding it, to an expression vector, a host cell, a method for producing it, as well as to using it for treating HER2-mediated diseases.

EFFECT: present invention enables producing the bispecific high-affinity antibody able to bind VEGF and HER2 simultaneously.

14 cl, 65 dwg, 16 tbl, 8 ex

Similar patents RU2547596C2

Title Year Author Number
ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) 2013
  • Fa Zhermejn
  • Li Chingvej V.
RU2639506C2
ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) 2008
  • Fa Zhermejn
  • Li Chingvehj V.
RU2514148C2
ANTI-BV8 ANTIBODIES AND USING THEM 2010
  • U, Sjumin'
  • Juj, Lan'Lan'
  • Ljan, Vehj-Chin
  • Mehn, Juj-Tszjuj G.
  • Ten', Dzhanet
  • U, Jan'
  • Ferrara, Napoleone
RU2559542C2
ANTIBODIES TO POLYUBIQUITIN AND METHODS OF APPLICATION THEREOF 2011
  • Diksit Vishva
  • Kelli Robert F.
  • Matsumoto Marissa L.
RU2603093C2
EXPRESSION AND SECRETION SYSTEM 2013
  • Tisar Devin
  • Chen Syaochen
  • Dennis Mark
  • Khotsel Isidro
RU2670491C2
ANTI-POLY-UBIQUITINATED ANTIBODIES AND METHODS OF APPLICATION 2012
  • Kelli Robert F.
  • Matsumoto Marissa L.
  • Diksit Vishva
RU2630637C2
DLL4 ANTIBODIES AND METHODS OF APPLICATION THEREOF 2007
  • Jan' Minkhong
  • Vu Jan'
RU2415869C2
ANTIBODIES AGAINST AXL AND THEIR APPLICATION 2011
  • Pej Lin
  • U Jan
  • E Sjaofen
RU2577986C2
OPTIMIZED OPTIONS OF ANTI-VEGF ANTIBODIES 2016
  • Koenig Patrick
  • Lee Chingwei Vivian
  • Rajagopal Karthikan
  • Famili Amin
  • Fuh Germaine
RU2763916C2
ANTIBODIES AGAINST NOTCH2 AND METHODS FOR APPLICATION THEREOF 2009
  • Sibel Kristian V.
  • Vu Jan
RU2580029C2

RU 2 547 596 C2

Authors

Bostrom, Dzhenni, M,

Fa, Dzhermejn

Dates

2015-04-10Published

2009-09-01Filed